Product information
From Health Canada
No match found
No other product was found with the same active ingredient group.
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Cancelled Post Market
Current status date:
2010-07-26
Original market date: See footnote 1
2007-05-15
Product name:
ADVICOR
DIN:
02293501
Product Monograph/Veterinary Labelling:
Date:
2010-10-29
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
SEPRACOR PHARMACEUTICALS INC
100
6790 Century Ave
Mississauga
Ontario
Canada
L5N 2V8
Class:
Human
Dosage form(s):
Tablet (Extended-Release) , Tablet (Immediate Release)
Route(s) of administration:
Oral
Number of active ingredient(s):
2
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
24:06.08 , 24:06.92
Anatomical Therapeutic Chemical (ATC): See footnote 4
C10BA01 LOVASTATIN AND NICOTINIC ACID
Active ingredient group (AIG) number:See footnote5
0251302004
Active ingredient(s) | Strength |
---|---|
LOVASTATIN | 40 MG |
NICOTINIC ACID | 1000 MG |